Research by Liu et al. has demonstrated that anti-ICAM1 neutralizing antibodies, by blocking ICAM1 expression, significantly inhibit the aggregation of CTCs with neutrophils, effectively curbing neutrophil-mediated metastasis of triple-negative breast cancer (TNBC) [96]. This evidence concerns the gene ICAM1 and triple-negative breast carcinoma.